DK IMAGING LTD
Company number 14120842 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
DK IMAGING LTD - Analysis Report
Company Number: 14120842
Analysis Date: 2025-07-29 15:03 UTC
Financial Health Assessment for DK IMAGING LTD (Year Ending 31 March 2024)
1. Financial Health Score: A-
Explanation:
DK Imaging Ltd demonstrates a robust financial position typical of a healthy micro-entity in its specialist medical practice sector. The company shows strong net current assets, positive net assets well above liabilities, and steady growth in equity. The score reflects excellent liquidity and solvency for its size, though the micro-entity status and limited scale moderate the grade slightly.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 738 | Minimal long-term assets, consistent with a service-based business. |
| Current Assets | 98,405 | Healthy short-term resources, predominantly cash or receivables. |
| Current Liabilities | 14,475 | Manageable short-term obligations, indicating good working capital management. |
| Net Current Assets | 84,076 | Strong positive working capital, a "healthy cash flow pulse". |
| Total Assets less CL | 84,814 | Reflects overall asset strength after settling immediate debts. |
| Net Assets (Equity) | 83,554 | Solid shareholder equity base, showing retained earnings and capital contributions. |
| Shareholders’ Funds | 83,554 | Equates to net assets, signaling no hidden liabilities or off-balance sheet concerns. |
3. Diagnosis: Financial Condition
DK Imaging Ltd exhibits the financial "vital signs" of a healthy and well-managed micro company. The balance sheet reveals a strong liquidity position with net current assets significantly exceeding current liabilities. This suggests the company can comfortably meet short-term obligations and has a buffer against unforeseen expenses—a sign of good financial resilience.
The modest fixed asset base aligns with its consultancy and specialist medical practice nature, where intangible assets like expertise and reputation are key. The company's equity has increased substantially from £31,619 in 2023 to £83,554 in 2024, indicating retained profits or additional capital infusion, contributing to a stronger financial "immune system."
There are no overdue filings or indications of financial distress, insolvency, or governance issues. The presence of related party transactions is transparent, with director loans repaid, showing disciplined financial stewardship.
Overall, the company shows no "symptoms of distress" such as negative working capital, excessive leverage, or dwindling equity. The business appears stable, with adequate resources to support ongoing operations and potential growth.
4. Recommendations: Improving Financial Wellness
Maintain Strong Cash Management: Continue monitoring working capital to sustain the healthy liquidity position. Consider forecasting cash flows to anticipate any seasonal fluctuations or unexpected costs.
Strategic Asset Investment: Evaluate opportunities to invest in technology or equipment that could enhance service delivery or efficiency, balancing this against the current low fixed asset base.
Profit Retention and Growth: Aim to retain profits to build a financial cushion further or consider prudent reinvestment to expand services or market reach.
Governance and Compliance: Keep up-to-date with filing deadlines and maintain transparent related party disclosures to avoid regulatory issues.
Risk Management: Although currently stable, consider formal risk assessments covering operational, financial, and regulatory risks to pre-empt any future challenges.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.